Sorrento Therapeutics, Inc.

SRNE · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$23,634$36,665$56,464$22,521
Short-Term Investments$26,344$90,217$0$0
Receivables$24,469$18,715$15,506$14,513
Inventory$9,976$8,106$1,831$3,362
Other Curr. Assets$11,950$19,286$12,433$27,192
Total Curr. Assets$96,373$172,989$86,234$67,588
Property Plant & Equip (Net)$138,435$126,498$73,913$76,272
Goodwill$80,269$79,525$43,554$38,298
Intangibles$136,902$259,705$73,675$63,308
Long-Term Investments$17,176$51,271$256,397$262,241
Tax Assets$0$78,080$62,931$60,354
Other NC Assets$3,685-$73,250-$60,882-$10,429
Total NC Assets$376,467$521,829$449,588$490,044
Other Assets$0$0$0$0
Total Assets$472,840$694,818$535,822$557,632
Liabilities
Payables$47,515$27,414$24,706$27,630
Short-Term Debt$30,166$43,519$26,834$42,905
Tax Payable$0$0$0$0
Deferred Revenue$652$1,108$4,485$3,643
Other Curr. Liab.$249,589$67,412$40,455$41,028
Total Curr. Liab.$327,922$139,453$96,480$115,206
LT Debt$104,338$194,058$142,559$251,199
Deferred Rev, NC$7,098$118,942$113,185$114,389
Deferred Tax Liab, NC$591$2,426$6,918$9,043
Other NC Liab.$54,560$161,810$35,949$35,039
Total NC Liab.$166,587$477,236$298,611$409,670
Other Liabilities$0$0$0$0
Cap. Leases$99,088$94,970$53,927$55,433
Total Liabilities$494,509$616,689$395,091$524,876
Equity
Pref Stock$0$0$0$0
Common Stock$52$32$28$18
Retained Earnings-$1,959,447-$1,386,604-$958,279-$659,818
AOCI$1,501$1,026$520-$270
Other Equity$1,939,289$1,464,294$1,122,882$738,658
Total Equity-$18,605$78,748$165,151$78,588
Supplemental Information
Minority Interest-$3,064-$619-$24,420-$45,832
Total Liab. & Tot. Equity$472,840$694,818$535,822$557,632
Net Debt$110,870$200,912$112,929$271,583